- Home
- KALA vs COCH Comparison
KALA vs COCH Comparison
Compare KALA & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- COCH
- Stock Information
- Founded
- KALA 2009
- COCH 1995
- Country
- KALA United States
- COCH United States
- Employees
- KALA N/A
- COCH N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- COCH Blank Checks
- Sector
- KALA Health Care
- COCH Finance
- Exchange
- KALA Nasdaq
- COCH Nasdaq
- Market Cap
- KALA 26.2M
- COCH 31.6M
- IPO Year
- KALA 2017
- COCH N/A
- Fundamental
- Price
- KALA $5.16
- COCH $1.46
- Analyst Decision
- KALA Strong Buy
- COCH Strong Buy
- Analyst Count
- KALA 3
- COCH 2
- Target Price
- KALA $14.00
- COCH $9.25
- AVG Volume (30 Days)
- KALA 71.9K
- COCH 19.6K
- Earning Date
- KALA 08-05-2025
- COCH 08-11-2025
- Dividend Yield
- KALA N/A
- COCH N/A
- EPS Growth
- KALA N/A
- COCH N/A
- EPS
- KALA N/A
- COCH N/A
- Revenue
- KALA N/A
- COCH $212,000.00
- Revenue This Year
- KALA N/A
- COCH $8.04
- Revenue Next Year
- KALA N/A
- COCH $15.39
- P/E Ratio
- KALA N/A
- COCH N/A
- Revenue Growth
- KALA N/A
- COCH N/A
- 52 Week Low
- KALA $2.92
- COCH $1.21
- 52 Week High
- KALA $11.20
- COCH $3.99
- Technical
- Relative Strength Index (RSI)
- KALA 61.92
- COCH 48.52
- Support Level
- KALA $4.36
- COCH $1.40
- Resistance Level
- KALA $5.75
- COCH $1.58
- Average True Range (ATR)
- KALA 0.53
- COCH 0.09
- MACD
- KALA 0.07
- COCH 0.01
- Stochastic Oscillator
- KALA 64.39
- COCH 47.83
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.